Effects of beta-receptor blocking drugs on cardiac metabolism.
D000818:Animals; D050260:Carbohydrate Metabolism; D002713:Chlorine; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000032:analysis; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000032:analysis; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007773:Lactates / Q000096:biosynthesis; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000032:analysis / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D014280:Triglycerides / Q000032:analysis
D004983:Ethanolamines; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D013565:Sympatholytics; D014280:Triglycerides; D002713:Chlorine; D006003:Glycogen; D011433:Propranolol; D005947:Glucose; D009638:Norepinephrine; D004837:Epinephrine